KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,692,793 | +2518.0% | 212,596 | +1521.8% | 0.00% | – |
| Q1 2023 | $141,053 | -95.6% | 13,109 | -93.9% | 0.00% | -100.0% |
| Q4 2022 | $3,199,099 | +1697.2% | 213,558 | +1441.4% | 0.00% | – |
| Q3 2022 | $178,000 | +50.8% | 13,855 | +13.3% | 0.00% | – |
| Q2 2022 | $118,000 | +4.4% | 12,233 | +7.3% | 0.00% | – |
| Q1 2022 | $113,000 | -15.0% | 11,396 | +1.4% | 0.00% | – |
| Q4 2021 | $133,000 | -8.3% | 11,240 | -11.7% | 0.00% | – |
| Q3 2021 | $145,000 | -5.2% | 12,736 | +15.9% | 0.00% | – |
| Q2 2021 | $153,000 | -88.0% | 10,985 | -78.1% | 0.00% | – |
| Q2 2020 | $1,276,000 | +2.4% | 50,074 | +12.9% | 0.00% | – |
| Q4 2018 | $1,246,000 | – | 44,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |